What Is Paget-Schroetter Syndrome?

Paget-Schroetter syndrome is a blood clot that forms in the subclavian or axillary vein of the upper arm, triggered by repetitive physical exertion rather than by a catheter, cancer, or prolonged immobility. It predominantly strikes young, otherwise healthy people who use their arms intensely, and it tends to show up in the dominant arm. Though rare in the general population, it is among the more common vascular emergencies in competitive athletes, and the speed at which it is recognized and treated has an outsized influence on whether the affected arm returns to full function.

What Happens Inside the Thoracic Outlet

The thoracic outlet is a narrow passageway between the collarbone and the first rib. The subclavian vein runs through this space every time you raise, rotate, or pull with your arm. In most people the vein passes through without trouble. But some people are born with a slightly narrower costoclavicular space, an extra-prominent first rib, or unusually tight scalene muscles. In these individuals, each overhead motion pinches the vein between bone and muscle like a garden hose caught under a car tire.

Over weeks or months of repetitive overhead activity, the inner lining of the vein sustains microtrauma and develops scarring. That progressive scarring narrows the vein and disrupts normal blood flow until, eventually, a clot forms and blocks the vessel entirely.¹ This is why the condition is sometimes called “effort thrombosis.” The clot itself is not the whole problem; the underlying anatomical compression that caused it will keep causing trouble unless it is addressed.

Who Gets It and Which Sports Carry the Highest Risk

Paget-Schroetter syndrome is most common in people in their twenties and thirties, though teenagers can develop it too. It favors the dominant arm and appears far more often in people whose activities involve repetitive overhead or forceful upper-body movements. A systematic review of 123 reported cases in athletes found that baseball and weightlifting accounted for the largest shares, at roughly 27% and 19% of cases, followed by swimming, football, and basketball.² But it also turns up in rowers, volleyball players, rock climbers, and anyone whose training hammers the shoulder girdle repeatedly.

The condition is not exclusive to elite competitors. Weekend warriors who suddenly ramp up weightlifting volume, manual laborers who spend hours with arms overhead, and even painters or construction workers can develop effort thrombosis if their anatomy predisposes them. The common thread is not athletic talent; it is the combination of a slightly too-tight thoracic outlet and enough repetitive arm use to push the vein past its tolerance.

Recognizing the Symptoms

The hallmark presentation is sudden, unexplained swelling of one arm, usually after a period of heavy exertion. The arm may turn dusky blue or reddish-purple, feel heavy, and ache deeply. Veins across the shoulder and upper chest sometimes become visibly distended as blood reroutes through collateral pathways.³ Some people also notice a tight, bursting sensation when they try to use the affected arm.

The trouble is that these symptoms overlap with a pulled muscle, a shoulder strain, or even an allergic reaction. Many patients, and some clinicians, initially write off the swelling as a sports injury. In one reported case of a 16-year-old cheerleader, initial ultrasound was unremarkable and she was sent home with supportive care. It took a second emergency visit nine days later, with persistent swelling and decreased range of motion, before imaging finally revealed an occlusive clot in the subclavian and axillary veins.⁴ That kind of delay is unfortunately common and can worsen outcomes.

How the Diagnosis Is Confirmed

Duplex ultrasound with Doppler is typically the first imaging test ordered when a clinician suspects upper-extremity deep vein thrombosis. It is noninvasive and widely available. However, the subclavian vein can be difficult to image clearly where it dips behind the collarbone, and a negative ultrasound does not rule out the diagnosis, as the cheerleader’s case illustrates. Contrast venography, in which dye is injected into the vein and X-ray images trace the flow, remains the gold standard because it maps the exact location and extent of the clot and shows whether the vein is compressed by surrounding structures.⁵ CT venography is often used as a practical middle ground, offering more anatomical detail than ultrasound without requiring a catheter.

The key point for anyone experiencing unexplained arm swelling after exertion is that a single negative ultrasound should not end the workup if symptoms persist. Clinicians experienced with this condition will push for further imaging or a repeat study if the clinical picture is suspicious.

Why Thrombophilia Screening Matters

Paget-Schroetter syndrome is, by definition, driven by mechanical compression. But not everyone with a slightly narrow thoracic outlet develops a clot. Individual clotting tendencies appear to tip the balance. One review found that roughly two-thirds of patients with subclavian vein thrombosis had an identifiable underlying clotting abnormality, and 90% of postoperative complications were associated with some form of thrombophilia.⁶

These abnormalities range from well-known genetic variants like factor V Leiden to elevated lipoprotein(a) levels, factor VIII elevations, or mildly low antithrombin.⁷ One case report described a 14-year-old with an elevated lipoprotein(a) level whose subclavian vein thrombosis was triggered by mechanical compression but likely made worse by her underlying hypercoagulable state.⁸ Screening for these disorders after diagnosis can affect treatment decisions, duration of anticoagulation, and the likelihood of recurrence after surgery.

There is another co-factor worth noting, especially in young women. Estrogen-containing contraceptives increase clotting risk on their own, and when layered onto the mechanical compression already present in the thoracic outlet, they can accelerate the progression from silent venous narrowing to full-blown thrombosis. The adolescent cheerleader mentioned earlier had recently started combined oral contraceptive pills before her clot formed.⁹

Treatment Approaches and Why Timing Is Critical

Treatment for Paget-Schroetter syndrome unfolds in stages, and urgency matters at every step. The goals are to dissolve the clot, relieve the underlying compression, and restore lasting blood flow through the vein.

The first step is usually anticoagulation to prevent the clot from growing, followed by catheter-directed thrombolysis, in which clot-dissolving drugs are delivered directly into the blocked vein through a catheter. Early endovascular intervention has been linked to better symptom relief and improved outcomes.¹⁰ Some centers also use mechanical aspiration thrombectomy devices alongside thrombolysis to physically remove clot material, which can speed the process and reduce the total dose of thrombolytic drugs needed.

Dissolving the clot alone, however, does not fix the structural problem. The compressed thoracic outlet is still there, and without addressing it, the vein will get pinched again the next time the arm is used vigorously. Anticoagulation without surgical decompression carries high rates of residual obstruction and recurrence.¹¹

Surgical Decompression and Its Outcomes

The definitive treatment is first rib resection, a surgery in which the first rib is removed to widen the costoclavicular space and relieve compression on the subclavian vein. This is typically combined with scalenectomy, the release of the anterior scalene muscle, and venolysis, freeing the vein from scar tissue that has adhered to surrounding structures.

The evidence strongly favors surgery over conservative management. A long-term outcome study found that patients who underwent surgical treatment had dramatically better functional scores than those managed without surgery. Surgically treated patients were more likely to continue their original lifestyle and sports activities: 84% of the surgical group compared with 40% of the nonoperative group.¹² Patients who initially tried conservative management but later needed surgery because of recurrence or persistent symptoms reported the worst functional outcomes of all, underscoring the cost of delay.

Separate research confirmed this pattern, finding that functional scores improved significantly in surgical patients while those managed conservatively showed no meaningful improvement. Early surgery also outperformed delayed surgery in terms of both rethrombosis rates and functional results.¹³

Does Timing of Surgery After Thrombolysis Matter?

Once the clot has been dissolved, the question becomes how quickly to proceed with first rib resection. Some centers operate within a few weeks; others wait longer while the patient remains on anticoagulation. A systematic review comparing early decompression (within about four weeks of thrombolysis) to later surgery found that the rates of rethrombosis before surgery were somewhat lower in the early group (about 7% versus 11%), and postoperative rethrombosis was also lower (13% versus 21%). Despite these differences, the overall long-term symptom relief was similar between the two groups, with roughly 90% of patients in both experiencing minimal or no symptoms at final follow-up.¹⁴

The practical takeaway is that early surgery may carry a slight edge in preventing recurrent clots during the waiting period, but patients who undergo later surgery still do well as long as surgical decompression is ultimately performed. The worst outcomes come from skipping surgery entirely.

What Happens After Surgery

Most patients undergo a venogram a few weeks after rib resection to check whether the vein has reopened fully. In many cases it has not, because scar tissue or residual narrowing persists even after the bony compression is gone. A large study found that about 60% of patients needed balloon angioplasty after their rib resection to stretch open the narrowed vein. Among those patients, venous patency climbed to roughly 83% at four to seven months and 87% at ten to fourteen months, with no significant difference based on how long the clot had been present before surgery.¹⁵

Another protocol described using routine postoperative venography to guide management: any patient with more than 50% narrowing after surgery received balloon dilation and extended anticoagulation. Using this approach, 79 of 84 patients had patent veins over long-term follow-up.¹⁶ In occasional cases where the vein remains stubbornly narrowed or re-occludes after dilation, venous stenting is considered. A study tracking 26 patients who received stents after thoracic outlet decompression reported three-year secondary patency rates around 91%, with 80% of patients remaining free of compression symptoms over a median follow-up of about four years.¹⁷

Postthrombotic Syndrome and Lingering Effects

Even with successful treatment, some patients develop postthrombotic syndrome, a condition in which chronic damage to the vein valves causes ongoing arm swelling, heaviness, and sometimes skin changes. A single-center study spanning ten years found postthrombotic syndrome in roughly 38% of patients managed with anticoagulation alone, versus about 20% of those treated with catheter-directed thrombolysis.¹⁸ These numbers reinforce the value of aggressive early clot removal: the faster and more completely the clot is cleared, the less lasting damage the vein valves sustain.

Postthrombotic syndrome in the arm tends to be milder than its counterpart in the leg, and many affected individuals manage it successfully with compression sleeves and activity modification. But for a young athlete whose livelihood or identity revolves around arm use, even mild residual swelling and fatigue can feel significant.

Returning to Sport After Treatment

The question that haunts most young patients is whether they can go back to their sport. The evidence is cautiously encouraging. In the long-term surgical outcome study, 84% of surgically treated patients were able to resume their original activities.¹⁹ Data on competitive athletes undergoing thoracic outlet decompression, though primarily studied in the neurogenic form, showed that 70% returned to the same or better level of athletic activity, with half doing so within a year. Younger age at the time of surgery was associated with faster rehabilitation.²⁰

Urgent referral to a specialist with experience in this condition is one of the strongest predictors of a good outcome, because it opens the window for thrombolysis and reduces the risk of pulmonary embolism, recurrent clots, and the need for more complex vein reconstruction down the line.²¹ Athletes and trainers who recognize sudden, unexplained arm swelling as a potential vascular emergency rather than a minor strain are doing the single most important thing they can to protect long-term function.

How Paget-Schroetter Differs From Other Forms of Thoracic Outlet Syndrome

Thoracic outlet syndrome is an umbrella term, and the venous form that produces Paget-Schroetter syndrome is just one of three subtypes. Neurogenic thoracic outlet syndrome, by far the most common, involves compression of the brachial plexus nerves rather than the vein. Its symptoms are numbness, tingling, weakness, and pain radiating down the arm and into the hand, often accompanied by neck pain and headaches. It is most frequently triggered by neck trauma or whiplash injuries. Arterial thoracic outlet syndrome, the rarest type, involves compression or damage to the subclavian artery, often in association with a cervical rib or anomalous first rib. Its symptoms are those of poor arterial blood flow: a cold, pale hand, weak pulse, and sometimes small blood clots traveling to the fingers.²²

The distinction matters because the treatments, urgencies, and prognoses differ substantially. A person with numbness and tingling in the fingers after a car accident is dealing with a completely different clinical problem than a baseball pitcher whose arm suddenly swells and turns blue after a game. Mixing up the subtypes leads to delayed or misdirected treatment, and unfortunately, misdiagnosis within the thoracic outlet syndrome family is not rare.

Adolescents and the Diagnostic Challenge

Paget-Schroetter syndrome is uncommon in teenagers but not unheard of, and it presents unique diagnostic and treatment challenges. A series of 21 pediatric patients (mean age around 16) found that the most common symptoms were swelling, discoloration, and pain, mirroring the adult presentation. All patients eventually underwent venography, endovascular intervention, and surgical decompression. Postoperative complications included hemothorax in two patients and pneumothorax in one, but symptoms recurred in only a single patient during follow-up.²³

The primary challenge in adolescents is that clinicians rarely expect a deep vein thrombosis in someone so young, so the diagnosis gets missed or delayed. Adding to the complexity, adolescent female athletes who use estrogen-containing contraception carry a compounded risk that is easy to overlook. Multidisciplinary teams involving pediatric hematologists, vascular surgeons, and interventional radiologists have produced the best-documented outcomes in this age group, partly because they are set up to think about both the mechanical problem and any underlying clotting tendency at the same time.